vimarsana.com
Home
Live Updates
Bristol Myers Squibb to buy Karuna Therapeutics for $14bn : vimarsana.com
Bristol Myers Squibb to buy Karuna Therapeutics for $14bn : vimarsana.com
Bristol Myers Squibb to buy Karuna Therapeutics for $14bn
Biopharmaceuticals giant Bristol Myers Squibb has announced it is spending $14bn to purchase Karuna Therapeutics, which develops treatments for people living with psychiatric and neurological conditions.
Related Keywords
Christopher Boerner ,
Dow Jones ,
Mizuho Securities ,
Cereval Therapeutics ,
Bristol ,
Myers ,
Squibb ,
Karuna ,
Therapeutics ,
4bn ,
Category All ,
Category Company News ,
Categorym A ,
Category International Companies ,
Category Sectorial Health Technology ,
Mostread Company News ,